Process for the preparation of regorafenib and its crystalline forms

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9790185
SERIAL NO

15324683

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a process for the preparation of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide or Regorafenib (I).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHILPA PHARMA LIFESCIENCES LIMITED12-6- 214/A-1 SHILPA HOUSE HYDERABAD ROAD RAICHUR KARNATAKA 584135

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akshay, Kant Chaturvedi Raichur, IN 3 0
Purohit, Prashant Raichur, IN 16 46
Ramachandrula, Krishna Kumar Vizianagaram, IN 1 0
Rampalli, Sriram Vizianagaram, IN 10 24
Upalla, Lav Kumar Vizianagaram, IN 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 17, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 17, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00